News - Midlands
£8m ABL injection for NeutraHealth
KBC Business Capital has provided an £8m ABL facility to support the refinancing of the senior debt facilities of Birmingham-based NeutraHealth. The new financing will enhance NeutraHealth’s working capital facilities and help to support the growth plans of the business, said KBC. The facility comprises a mixture of accounts receivable, inventory and a cash-flow loan. AIM-listed NeutraHealth manufactures, distributes and sells neutraceutical products such as vitamins, minerals and supplements – mostly in the form of pills and capsules.